AVANIR Pharmaceuticals (FRA:AV2B) Gross Profit : €82.93 Mil (TTM As of Sep. 2014)

AVANIR Pharmaceuticals Gross Profit Chart

AVANIR Pharmaceuticals Annual Data
	Trend	Sep05	Sep06	Sep07	Sep08	Sep09	Sep10	Sep11	Sep12	Sep13	Sep14
Gross Profit		Get a 7-Day Free Trial					2.06	7.31	30.38	53.27	86.53

AVANIR Pharmaceuticals Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Gross Profit	Get a 7-Day Free Trial															15.28	18.58	18.49	19.83	26.02

Competitive Comparison of AVANIR Pharmaceuticals's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, AVANIR Pharmaceuticals's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AVANIR Pharmaceuticals's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AVANIR Pharmaceuticals's Gross Profit distribution charts can be found below:

* The bar in red indicates where AVANIR Pharmaceuticals's Gross Profit falls into.

AVANIR Pharmaceuticals Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

AVANIR Pharmaceuticals's Gross Profit for the fiscal year that ended in Sep. 2014 is calculated as

AVANIR Pharmaceuticals's Gross Profit for the quarter that ended in Sep. 2014 is calculated as

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €82.93 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

AVANIR Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2014 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

AVANIR Pharmaceuticals  (FRA:AV2B) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

AVANIR Pharmaceuticals had a gross margin of 102.54% for the quarter that ended in Sep. 2014 => Durable competitive advantage

AVANIR Pharmaceuticals Gross Profit Related Terms

Thank you for viewing the detailed overview of AVANIR Pharmaceuticals's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

AVANIR Pharmaceuticals (FRA:AV2B) Business Description